The Interpublic Group of Companies, Inc. (IPG) — closed signal from October 3, 2025
Partial Published before the outcome was known, scored automatically when the window closed on January 1, 2026.
Predicted vs. what happened
What happened
Reached 41% of the predicted growth at its peak, without hitting the target.
The thesis — published October 3, 2025
IPG looks ready for a bounce after a long slide. Recent price action suggests the selloff may be easing and buyers are starting to show up. A big win with Bayer's global marketing work and fresh quality certifications add proof the business can execute. If the overall market stays steady, ad budgets could level out, giving the stock room to recover over the next three months. Main risks are weaker ad demand and currency swings.
Primary drivers
- Price slump looks overdone; fresh signs show buyers stepping back in.
- Winning Bayer's global marketing work boosts credibility and future fees.
- New ISO quality certifications confirm strong, consistent processes.
- If companies stop cutting ads, revenue can steady and support a rebound.
How it played out
IPG: the thesis did not reach its target
Lyra published IPG at $26.59 on 2025-10-03 with a short-term bounce thesis. It expected 15% growth to $30.57. The thesis pointed to an overdone price slump, signs of buyers returning, Bayer's global marketing work, ISO quality certifications, and steadier ad budgets if companies stopped cutting ads.
Inside the window, IPG rose to a peak of $28.24 on 2025-10-22, a 6.2% gain. It stayed below the $30.57 target and never reached it. By 2026-01-01, it ended at $24.57. The thesis partially played out early, but it missed the target.
What happened during the window
On 2025-11-26, Omnicom completed its acquisition of Interpublic Group. On 2025-12-02, Axios reported that Omnicom planned about 4,000 layoffs after the IPG deal.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.